Work

Pediatric Preclinical Testing Consortium Evaluation of the Anti-CD123 Antibody-Drug Conjugate, IMGN632, Against Patient-Derived Xenograft Models of Pediatric Acute Lymphoblastic Leukemia

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-159867

Authors: Richard B Lock, Kathryn Evans, Joanna Randall, Stephen W Erickson, Eric J Earley, Steven Neuhauser, Tim Stearns, Vivek Philip, Beverly A Teicher, Krystal Watkins, Callum M Sloss, Patrick A Zweidler-McKay, Malcolm A Smith

Institutions: UNSW Sydney, Children's Cancer Institute Australia, RTI International, Jackson Laboratory, National Cancer Institute, ImmunoGen (United States)

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310162573

FWCI: 0.211

Cites:

Cited by: 1

Related to: 10